The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

The ongoing trial is aiming to enrol around 36 IPF subjects. Credit: photobyphotoboy/Shutterstock. GRI Bio has announced encouraging six-week interim safety outcomes ...

Pliant plans to submit the full outcomes from the BEACON-IPF trial for future publication. Credit: Lana Leon/Shutterstock. Pliant Therapeutics has discontinued the bexotegrast development for ...

Tango Therapeutics is focused on advancing precision medicine for cancer treatment. Credit: MacroEcon/Shutterstock. Tango Therapeutics has dosed the first subject in the Phase I/II trial assessing ...

The lead investigator is calling on more research into the drug’s safety profile and cost-effectiveness as a treatment for depression. Image credit: My Ocean Production / Shutterstock. A Parkinson’s ...